BRZ-79461-08596
2 vaccinations
4 coded responses
11 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 958 / CA
- Registered
- 2021-05-25
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-03
Dose 1 — Pfizer-BioNTech
-
2021-05-25
Registered in v-safe
-
2021-05-25
Dose 2 — Pfizer-BioNTech
-
2021-05-25
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-05-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-05-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Muscle or body achesAdult check-in
- 2021-05-29
- 2021-05-30
-
2021-06-08
Survey response — day 14, dose 2MedDRA: Pyrexia — Feeling: FairFree text: Low FeverMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-15
Survey response — day 21, dose 2MedDRA: Headache — Feeling: FairFree text: HeadacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-22
Survey response — day 28, dose 2MedDRA: Fatigue, Headache — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Head aches and ExhaustionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-29
- 2021-07-06
-
2021-08-24
Survey response — 3 months, dose 2MedDRA: Dyspnoea, Fatigue, Headache, Pyrexia, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: COVID congestion, fever, difficulty breathing headache and exhaustionMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-24
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2021-08-25
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-03 | Pfizer-BioNTech | |
| 2 | 2021-05-25 | Pfizer-BioNTech |
Call center
1 call center case
1 successful
Free text
Release 8 — day 14, dose 2
Symptoms: Low Fever
Release 9 — day 21, dose 2
Symptoms: Headache
Release 9 — day 28, dose 2
Symptoms: Head aches and Exhaustion
Release 9 — 3 months, dose 2
Symptoms: COVID congestion, fever, difficulty breathing headache and exhaustion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dyspnoea | ✓ | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release